Streptomyces sulfonofaciens Miyadoh et al. (ATCC® 31892)

Strain Designations: SF-2103  /  Type Strain: yes  /  Biosafety Level: 1

Strain Designations SF-2103
Application
Produces pluracidomycin SF-2103A
Isolation
Soil, Wakayama Pref., Japan
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol® no
Type Strain yes (type strain)
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor Meiji Seika Kaisha, Ltd.
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Isolation
Soil, Wakayama Pref., Japan
References

Miyadoh S, et al. Streptomyces sulfonofaciens sp. nov. Int. J. Syst. Bacteriol. 33: 321-324, 1983.

Ito T, et al. A novel beta-lactamase inhibitor, SF-2103A produced by a Streptomyces. J. Antibiot. 35: 533-535, 1982. PubMed: 6980216

Niwa T, et al. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor. J. Antibiot. 39: 943-955, 1986. PubMed: 3019978

type strain

type strain

Cross References

Nucleotide (GenBank) : AF318042 Streptomyces sulfonofaciens 16S ribosomal RNA gene, partial sequence.

Nucleotide (GenBank) : AF141676 Streptomyces sulfonofaciens isopenicillin N synthase (pcbC) gene, partial cds.